| PD-1 blockade in mismatch repair–deficient, locally advanced rectal cancer A Cercek, M Lumish, J Sinopoli, J Weiss, J Shia, M Lamendola-Essel, ... New England Journal of Medicine 386 (25), 2363-2376, 2022 | 1161 | 2022 |
| Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy GR Varadhachary, EP Tamm, JL Abbruzzese, HQ Xiong, CH Crane, ... Annals of surgical oncology 13, 1035-1046, 2006 | 1033 | 2006 |
| Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial PJ Loehrer Sr, Y Feng, H Cardenes, L Wagner, JM Brell, D Cella, P Flynn, ... Journal of Clinical Oncology 29 (31), 4105-4112, 2011 | 977 | 2011 |
| Borderline resectable pancreatic cancer: the importance of this emerging stage of disease MHG Katz, PWT Pisters, DB Evans, CC Sun, JE Lee, JB Fleming, ... Journal of the American College of Surgeons 206 (5), 833-846, 2008 | 954 | 2008 |
| Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head DB Evans, GR Varadhachary, CH Crane, CC Sun, JE Lee, PWT Pisters, ... Journal of Clinical Oncology 26 (21), 3496-3502, 2008 | 872 | 2008 |
| Pancreaticoduodenectomy with vascular resection: margin status and survival duration JF Tseng, CP Raut, JE Lee, PWT Pisters, JN Vauthey, EK Abdalla, ... Journal of Gastrointestinal Surgery 8, 935-950, 2004 | 697 | 2004 |
| Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma CP Raut, JF Tseng, CC Sun, H Wang, RA Wolff, CH Crane, R Hwang, ... Annals of surgery 246 (1), 52-60, 2007 | 689 | 2007 |
| Adoption of total neoadjuvant therapy for locally advanced rectal cancer A Cercek, CSD Roxburgh, P Strombom, JJ Smith, LKF Temple, GM Nash, ... JAMA oncology 4 (6), e180071-e180071, 2018 | 581 | 2018 |
| Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators MHG Katz, JB Fleming, P Bhosale, G Varadhachary, JE Lee, R Wolff, ... Cancer 118 (23), 5749-5756, 2012 | 568 | 2012 |
| Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma MHG Katz, H Wang, JB Fleming, CC Sun, RF Hwang, RA Wolff, ... Annals of surgical oncology 16, 836-847, 2009 | 561 | 2009 |
| Neoadjuvant treatment response as an early response indicator for patients with rectal cancer IJ Park, YN You, A Agarwal, JM Skibber, MA Rodriguez-Bigas, C Eng, ... Journal of clinical oncology 30 (15), 1770-1776, 2012 | 550 | 2012 |
| Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response JA Ajani, K Winter, GS Okawara, JH Donohue, PWT Pisters, CH Crane, ... Journal of clinical oncology 24 (24), 3953-3958, 2006 | 548 | 2006 |
| Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head GR Varadhachary, RA Wolff, CH Crane, CC Sun, JE Lee, PWT Pisters, ... Journal of clinical oncology 26 (21), 3487-3495, 2008 | 537 | 2008 |
| Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy JJ Smith, P Strombom, OS Chow, CS Roxburgh, P Lynn, A Eaton, ... JAMA oncology 5 (4), e185896-e185896, 2019 | 526 | 2019 |
| Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications CR Churi, R Shroff, Y Wang, A Rashid, HSC Kang, J Weatherly, M Zuo, ... PloS one 9 (12), e115383, 2014 | 481 | 2014 |
| Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic … TS Hong, JY Wo, BY Yeap, E Ben-Josef, EI McDonnell, LS Blaszkowsky, ... Journal of Clinical Oncology 34 (5), 460-468, 2016 | 470 | 2016 |
| Hilar cholangiocarcinoma: expert consensus statement JC Mansour, TA Aloia, CH Crane, JK Heimbach, M Nagino, JN Vauthey Hpb 17 (8), 691-699, 2015 | 458 | 2015 |
| Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer P Das, JM Skibber, MA Rodriguez‐Bigas, BW Feig, GJ Chang, RA Wolff, ... Cancer 109 (9), 1750-1755, 2007 | 434 | 2007 |
| Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration TM Breslin, KR Hess, DB Harbison, ME Jean, KR Cleary, AP Dackiw, ... Annals of surgical oncology 8, 123-132, 2001 | 434 | 2001 |
| Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline RT Shroff, EB Kennedy, M Bachini, T Bekaii-Saab, C Crane, J Edeline, ... Journal of Clinical Oncology 37 (12), 1015-1027, 2019 | 427 | 2019 |
